These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 9830064)
1. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. Mühlenbeck F; Haas E; Schwenzer R; Schubert G; Grell M; Smith C; Scheurich P; Wajant H J Biol Chem; 1998 Dec; 273(49):33091-8. PubMed ID: 9830064 [TBL] [Abstract][Full Text] [Related]
2. JNK/SAPK activity contributes to TRAIL-induced apoptosis. Herr I; Wilhelm D; Meyer E; Jeremias I; Angel P; Debatin KM Cell Death Differ; 1999 Feb; 6(2):130-5. PubMed ID: 10200559 [TBL] [Abstract][Full Text] [Related]
3. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction. Wajant H; Johannes FJ; Haas E; Siemienski K; Schwenzer R; Schubert G; Weiss T; Grell M; Scheurich P Curr Biol; 1998 Jan; 8(2):113-6. PubMed ID: 9427646 [TBL] [Abstract][Full Text] [Related]
4. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells. Vivo C; Liu W; Broaddus VC J Biol Chem; 2003 Jul; 278(28):25461-7. PubMed ID: 12707267 [TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. Varfolomeev E; Maecker H; Sharp D; Lawrence D; Renz M; Vucic D; Ashkenazi A J Biol Chem; 2005 Dec; 280(49):40599-608. PubMed ID: 16227629 [TBL] [Abstract][Full Text] [Related]
6. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Lin Y; Devin A; Cook A; Keane MM; Kelliher M; Lipkowitz S; Liu ZG Mol Cell Biol; 2000 Sep; 20(18):6638-45. PubMed ID: 10958661 [TBL] [Abstract][Full Text] [Related]
7. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. MacFarlane M; Cohen GM; Dickens M Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718 [TBL] [Abstract][Full Text] [Related]
8. JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alpha. Herr I; Wilhelm D; Böhler T; Angel P; Debatin KM Int J Cancer; 1999 Jan; 80(3):417-24. PubMed ID: 9935184 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538 [TBL] [Abstract][Full Text] [Related]
10. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Juo P; Kuo CJ; Yuan J; Blenis J Curr Biol; 1998 Sep; 8(18):1001-8. PubMed ID: 9740801 [TBL] [Abstract][Full Text] [Related]
11. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis. Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844 [TBL] [Abstract][Full Text] [Related]
12. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. Harper N; Hughes M; MacFarlane M; Cohen GM J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308 [TBL] [Abstract][Full Text] [Related]
13. Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3-like proteases but is dispensable for cell death. Ozaki I; Tani E; Ikemoto H; Kitagawa H; Fujikawa H J Biol Chem; 1999 Feb; 274(9):5310-7. PubMed ID: 10026138 [TBL] [Abstract][Full Text] [Related]
14. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Song JH; Bellail A; Tse MC; Yong VW; Hao C J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480 [TBL] [Abstract][Full Text] [Related]
15. Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells. Platzbecker U; Ward JL; Deeg HJ Br J Haematol; 2003 Aug; 122(3):489-97. PubMed ID: 12877678 [TBL] [Abstract][Full Text] [Related]
16. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. Lüschen S; Ussat S; Scherer G; Kabelitz D; Adam-Klages S J Biol Chem; 2000 Aug; 275(32):24670-8. PubMed ID: 10827087 [TBL] [Abstract][Full Text] [Related]
17. The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis. Lee MW; Park SC; Yang YG; Yim SO; Chae HS; Bach JH; Lee HJ; Kim KY; Lee WB; Kim SS FEBS Lett; 2002 Feb; 512(1-3):313-8. PubMed ID: 11852102 [TBL] [Abstract][Full Text] [Related]
18. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965 [TBL] [Abstract][Full Text] [Related]
19. Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression. Wang WH; Grégori G; Hullinger RL; Andrisani OM Mol Cell Biol; 2004 Dec; 24(23):10352-65. PubMed ID: 15542843 [TBL] [Abstract][Full Text] [Related]
20. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. Toyoshima F; Moriguchi T; Nishida E J Cell Biol; 1997 Nov; 139(4):1005-15. PubMed ID: 9362518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]